Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
Atrial Fibrillation
About this trial
This is an interventional treatment trial for Atrial Fibrillation
Eligibility Criteria
Inclusion criteria: History of symptomatic atrial fibrillation that significantly disrupts the patient's customary daily living activities History of congestive heart failure and/or ischemic heart disease Sinus rhythm (normal heart rhythm) upon entry to the 30 day screening period for the study At least one episode of symptomatic atrial fibrillation during the screening period, with a spontaneous return to sinus rhythm. Sinus rhythm immediately prior to dosing Exclusion criteria: Previously unsuccessful cardioversions within 60 days of screening period Failed to respond to any Class III antiarrhythmic drugs Qualifying arrhythmia due to acute reversible illness, acute myocardial infarction, and/or cardiac or thoracic surgery within one month prior to randomization Previously in an azimilide study
Sites / Locations
- Cardiovascular Assoc. PC
- The Heart Group, PC
- Southern Arizona VA Health Care System, Section of Cardiology (1-111C)
- University Medical Center
- University of Arkansas Medical Center
- Cardiovascular Associates of Penisula
- Capitol Interventional Cardiology
- VA Central California Health Care System
- Valley Research
- Grass Valley Cardiology
- San Diego Cardiovascular Associates
- Good Samaritan Hospital
- LAC+USC Medical Center
- Cardiology Section, West Los Angeles VA Hospital
- Merced Heart Associates
- Sutter Gould Medical Foundation
- ARI Clinical Trials
- Regional Cardiology Assoc.
- Sacramento Heart and Vascular Medical Associates
- Cardiology Associates
- Aurora Denver Cardiology
- Western Cardiology Assoc.
- Hartford Hospital
- The George Washington University MFA
- Cardiology Consultants
- C/O Research Office Attn: Cardiovascular Research Dept.
- SW Florida Heart Group/Health Park Medical Center
- Jacksonville Center for Clinical Research
- Watson Clinic, LLP
- Khalid Hassan Sheikh 80 Fontenberry Road
- Florida Cardiology
- Cardiology Research Assiocates
- VA Medical Center
- Mount Sinal Hospital Medical Center
- Elgin Cardiology Associates
- Illinois Heart & Lung Research Center, SC
- The Center for Advanced Cardiology
- Heart Center Medical Group
- The Care Group
- Professional Research Network of Kansas
- University of Louisville-Cardiology
- Louisville Cardiology Medical Group, P.S.C
- Cardiovascular Institute of the South
- Richard Gilmore, MD 501 S Ryan Street
- Cardiovascular of the South
- Cardiovascular Institute of the South
- Tulane University
- Medical Research Institute
- Cardiovascular Institute of the South
- Maine Medical Center
- Boston Medical Center
- University of Massachusett
- Thoracic & Cardiovascular Healthcare Foundation
- Nisus Research
- Riverside Osteopathic Hospital
- VA Medical Center Therapeutic Section
- Regional Heart Center
- Fairview Range Regional Health Services
- St. Patrick Hosp/Western Mt. Clinic Cardiology
- Internal Medical Associates
- William Olney, MD 21 Whitehall Rd, Suite 200
- Cardiology & Int. Medicine
- Duke Medical Center
- Altru Health System Research Center
- Lindner Clinical Trial Ctr.
- University Hospitals of Cleveland
- MidWest Cardiology Research Foundation
- Oklahoma Foundation for Cardiovascular Research
- Hillsboro Cardiology
- Oregon Health Sciences University
- Heart Care Group PC
- Tri-State Medical Group Cardiology
- Milton S. Hershey Medical Center
- The Pavillion
- UPHS/Presbyterian Medical Center
- Cardiovascular and Critical Care Associates, P.C.
- Charleston Cardiology
- Stern Cardiovascular Center Research Department
- UT Southwestern Medical Center
- Methodist Hospital
- Heart and Vascular Inst. of Texas, PA
- MedSource, Inc
- Riverside Regional Medical Center
- Daniel Gottlieb, MD 16259 Sylvester Road SW, Suite 401
- Beloit Clinic, SC
- Dean/Riverview Clinic
- University of Wisconsin Madison
- Marshfield Clinic
- Heart Health Institute
- Heart Health Research Center
- University of Calgary
- Cardiology Research St. Paul's Hospital
- Hamilton Health Science Corp.
- Cardiac Investigation Unit
- Niagara Health System Greater Niagara General Hospital
- University of Ottawa Heart Institute
- Neureka Research Corporation
- St. Michael's Hospital
- Montreal Heart Institute
- Recharche Cardiologie
- Chum Hotel Dieu
- Hospital Sacre-Soeur de Montreal
- Quebec Heart Institute
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
1
2
Placebo tablets
125 mg azimilide tablets